CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

A Growing Reliance on Outsourcing Warrants...

Greg Aimi, Vice President, Team Manager, Supply...

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

A Growing Reliance on Outsourcing Warrants...

Greg Aimi, Vice President, Team Manager, Supply...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review
Tweet

To open the study process to a much wider community of stakeholders, software resources that promote collaboration, data sharing, and interactive meetings allow groups to work together regardless of where they are located.


Current biotechnology mainly focuses on medicine. Small start-ups are developing new treatment methods for rare and complex disorders and genetic testing to classify inherited diseases, global pharmaceutical firms, and government funding agencies in this area. Other fields of biotechnology include alternative energy, agriculture, and environmental science.


Top biotechnology developments include:


Increased Stakeholder Collaboration


The opportunity to facilitate cooperation among stakeholders representing numerous organizations, whether global corporations, smaller companies, academic institutions, or government research organizations, is another advantage of cloud computing. To open the study process to a much wider community of stakeholders, software resources that promote collaboration, data sharing, and interactive meetings allow groups to work together regardless of where they are located. 


Increased collaboration presents a potential threat to practitioners in biotechnology. For wider teams collaborating on projects, and with some projects taking several years to gain regulatory approval or produce a return on investment, with the technologies they are making, people and the organizations they serve need to consider intellectual property rights. Otherwise, the products they make could not benefit financially from them.


Growth in Personalized Diagnosis of Rare Diseases


From 2.7 billion dollars for the Human Genome Project in 1990 to less than 300 dollars currently, and possibly less than 100 dollars shortly, the decreased cost of genetic sequencing allows for far more rigorous screening and intervention targeting of study subjects. This has allowed customized therapy strategies and tailored therapies to be created, which are more successful than less precise treatments since they rely on the genetic and molecular composition of a patient.


The main area of focus for tailored treatments is cancer care. One famous example is blood cancer, such as leukemia, where a procedure called CAR T-cell therapy targets the immune cells of a patient, and the immune system can attack tumors.


Weekly Brief

loading

Weekly Brief

Subscribe

loading
Towards a New World Order
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Data Science In R&D: It Is About Culture

Philippe MARC, Executive Director, Global Head of Integrated Data Science, Novartis
Data Science In R&D: It Is About Culture

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Roman Mathaes, Head of Pharmaceutical Services and Cristina GrigoreCristina Grigore, at Lonza
Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Chris Dobbs, CEng., MIET, Head of Technical Engineering, PCI Pharma Services
Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Encouraging Innovation in Healthcare in a COVID - 19 World

Duncan Turner, General Partner, SOSV, Managing Director, HAX
Encouraging Innovation in Healthcare in a COVID - 19 World
How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

Gil Carrasquinho, VP Head of Cell Therapy, Santen
Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Craig Herron, Managing Director, iSelect Fund

Addressing the Expanded Role of Patient Engagement in Clinical Research

Denis Curtin, PhD, Principal, eCOA & Patient Engagement, Signant Health
Addressing the Expanded Role of Patient Engagement in Clinical Research

The Future of Imaging and the Role of the Pathology Data Scientist in Drug Discovery

Jason Hipp, Senior Director, Head of Pathology Data Science & Innovation, Translational, AstraZeneca
The Future of Imaging and the Role of the Pathology Data Scientist in Drug Discovery
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/top-biotech-developments-to-watch-for-nwid-272.html